TRA2A Antikörper (C-Term)
Kurzübersicht für TRA2A Antikörper (C-Term) (ABIN7185618)
Target
Alle TRA2A Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Kreuzreaktivität
- Human, Maus
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from the C-terminal region of Human Tra-2alpha.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB:1:500-1:2000, IHC:1:100-1:300, IF:1:200-1:1000, ELISA:1:20000,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- TRA2A (Transformer 2 alpha Homolog (TRA2A))
-
Andere Bezeichnung
- TRA2A
-
Hintergrund
- AWMS1 antibody, HSU53209 antibody, htra-2 alpha antibody, Putative MAPK activating protein PM24 antibody, TRA 2 alpha antibody, TRA 2A antibody, TRA-2 alpha antibody, TRA2 alpha antibody, TRA2-alpha antibody, TRA2A antibody, TRA2A_HUMAN antibody, Tra2alpha antibody, Transformer 2 alpha antibody, Transformer 2 protein homolog antibody, Transformer-2 protein homolog A antibody, Transformer-2 protein homolog alpha antibody
-
UniProt
- Q13595
Target
-